A "sandwich" strategy for functional cure of chronic hepatitis B

Emerg Microbes Infect. 2018 May 17;7(1):91. doi: 10.1038/s41426-018-0092-3.

Authors

Xuan-Yi Wang^{1

2}, Yu-Mei Wen³

Affiliations

¹ Key Laboratory Medical Molecular Virology, MoE/MoH, Shanghai Medical College, Fudan University, Shanghai, China, 200032.
² Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China, 200032.
³ Key Laboratory Medical Molecular Virology, MoE/MoH, Shanghai Medical College, Fudan University, Shanghai, China, 200032. ymwen@shmu.edu.cn.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Antibodies, Neutralizing / immunology
Antibodies, Neutralizing / therapeutic use*
Antibodies, Viral / immunology
Antibodies, Viral / therapeutic use*
Antiviral Agents / therapeutic use*
Gene Products, pol / genetics
Hepatitis B Core Antigens / genetics
Hepatitis B Surface Antigens / blood
Hepatitis B Surface Antigens / genetics
Hepatitis B Surface Antigens / immunology
Hepatitis B virus / genetics
Hepatitis B, Chronic / drug therapy*
Humans
Interferon-alpha / therapeutic use
Polyethylene Glycols / therapeutic use
Recombinant Proteins / therapeutic use
Trans-Activators / genetics
Viral Load
Viral Regulatory and Accessory Proteins

Substances

Antibodies, Monoclonal
Antibodies, Neutralizing
Antibodies, Viral
Antiviral Agents
Gene Products, pol
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Interferon-alpha
P protein, Hepatitis B virus
Recombinant Proteins
Trans-Activators
Viral Regulatory and Accessory Proteins
hepatitis B virus X protein
Polyethylene Glycols
peginterferon alfa-2a